Amarin Corporation plc(AMRN)
Pharmaceuticals
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-08-05 | Berg Aaron President and CEO | Purchase | +160,000 | +24.79%805,380 | $0.64 | $102,400 | View SEC filing | |
| 2024-01-24 | Holt Patrick President and CEO | Purchase | +14,426 | +4.81%314,426 | $1.09 | $15,724 | View SEC filing | |
| 2023-12-14 | Ketchum Steven B Chief Scientific Officer | Sale | -34,131 | -5.69%566,100 | $0.79 | $26,963 | View SEC filing | |
| 2023-08-16 | Holt Patrick President and CEO | Purchase | +300,000 | +100.00%300,000 | $1.04 | $312,315 | View SEC filing | |
| 2022-06-15 | WOLD OLSEN PER Director | Purchase | +55,000 | +58.51%149,000 | $1.69 | $92,730 | View SEC filing | |
| 2021-12-16 | Zakrzewski Joseph S Director | Purchase | +12,000 | +6.50%196,547 | $3.25 | $38,999 | View SEC filing | |
| 2021-08-13 | Kalb Michael Wayne SVP and CFO | Sale | -120,000 | -36.92%205,010 | $5.25 | $630,240 | View SEC filing | |
| 2021-06-07 | STACK DAVID M Director | Purchase | +15,000 | +60.00%40,000 | $4.56 | $68,465 | View SEC filing | |
| 2021-02-03 | Ketchum Steven B Chief Scientific Officer | Sale | -217,728 | -36.24%382,996 | $8.06 | $1,754,134 | View SEC filing | |
| 2021-01-29 | Ketchum Steven B Chief Scientific Officer | Sale | -421,629 | -52.07%388,112 | $8.01 | $3,378,131 | View SEC filing | |
| 2020-12-02 | STACK DAVID M Director | Purchase | +25,000 | +100.00%25,000 | $4.86 | $121,518 | View SEC filing | |
| 2020-11-12 | THERO JOHN F President and CEO | Sale | -567,405 | -17.16%2,739,000 | $4.08 | $2,317,158 | View SEC filing | |
| 2020-03-06 | THERO JOHN F President and CEO | Sale | -200,000 | -7.46%2,480,441 | $15.99 | $3,198,700 | View SEC filing | |
| 2020-01-03 | Zakrzewski Joseph S Director | Sale | -300,000 | -78.01%84,547 | $20.94 | $6,282,870 | View SEC filing | |
| 2019-12-18 | Zakrzewski Joseph S Director | Sale | -100,000 | -54.19%84,547 | $25.83 | $2,583,380 | View SEC filing | |
| 2019-12-18 | Berg Aaron CHIEF COMMERCIAL OFFICER | Sale | -43,253 | -24.43%133,806 | $25.46 | $1,101,364 | View SEC filing | |
| 2019-12-18 | Kalb Michael Wayne SVP and CFO | Sale | -25,000 | -53.70%21,552 | $23.36 | $584,012 | View SEC filing | |
| 2019-11-21 | THERO JOHN F President and CEO | Sale | -274,454 | -10.49%2,342,285 | $22.65 | $6,217,371 | View SEC filing | |
| 2019-11-13 | Ekman Lars Director | Sale | -38,600 | -100.00%0 | $19.35 | $746,759 | View SEC filing | |
| 2019-11-13 | THERO JOHN F President and CEO | Sale | -475,546 | -15.38%2,616,739 | $17.12 | $8,143,452 | View SEC filing | |
| 2019-11-07 | Ekman Lars Director | Sale | -6,400 | -100.00%0 | $18.00 | $115,230 | View SEC filing | |
| 2019-09-05 | Ekman Lars Director | Sale | -91,016 | -100.00%0 | $15.01 | $1,365,722 | View SEC filing | |
| 2019-07-12 | STACK DAVID M Director | Sale | -51,991 | -100.00%0 | $22.28 | $1,158,354 | View SEC filing | |
| 2019-07-05 | Zakrzewski Joseph S Director | Sale | -100,000 | -54.19%84,547 | $23.82 | $2,381,580 | View SEC filing | |
| 2019-07-03 | Kennedy Joseph T General Counsel | Sale | -54,186 | -63.42%31,260 | $19.52 | $1,057,906 | View SEC filing |
1-25 of 150